202172
Other LAPiS Study, a Phase I/II Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With HF is posted on ClinicalTrials.gov
2021622
Congress Kikuo Yasui, COO speaks at the International Society for Stem Cell Research (ISSCR) 2021, "Driving Change in Regenerative Medicine Through Global Partnerships: Organized by Novo Nordisk Stem Cell R&D"
2021615
Congress Keiichi Fukuda, CEO gave a presentation titled "Clinical Application of Human iPS Cell-Derived Ventricular Cardiomyocytes for Heart Failure Treatment" at Deep Tech in Asia: Stem Cell Innovations by SGInnovate.
202161
PR Heartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure
2021421
Media Heartseed was featured as a cover story in Startup City Magazine's "Top 10 Startups in Japan"